Mangoceuticals, Inc. Enters into Lease Agreement and Separation Agreement

Mangoceuticals, Inc. (the 'Company') has entered into a Lease Agreement with SVHQ, LLC to lease approximately 2,467 square feet of office space in Dallas, Texas, with a term of 60 months commencing on November 1, 2025. The monthly base rent is $4,852, with additional rent for real estate taxes, insurance, and maintenance costs. The Company also entered into a Separation Agreement with its former Chief Operating Officer, Amanda Hammer, effective October 22, 2025. The agreement includes a separation payment of nine months of Hammer's regular compensation, to be paid in monthly installments starting November 1, 2025. Additionally, the Company reported the conversion of Series B Convertible Preferred Stock into common stock by Indigo Capital LP and Platinum Point Capital, LLC.